Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2005
03/10/2005US20050054678 Nitrogenous five-membered ring compounds
03/10/2005US20050054672 Quinolinone derivatives
03/10/2005US20050054668 Antagonists of MCP-1 function and methods of use thereof
03/10/2005US20050054662 Quinazoline derivatives as antitumor agents
03/10/2005US20050054657 Induce immunology response; anticancer agents
03/10/2005US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders
03/10/2005US20050054654 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054643 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
03/10/2005US20050054627 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005CA2537487A1 Piperazine substituted compounds used as calcium channel blockers
03/10/2005CA2537141A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
03/10/2005CA2537123A1 New compounds
03/10/2005CA2536871A1 Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders
03/10/2005CA2536784A1 Process for the production of polymorphs of rosiglitazone maleate
03/10/2005CA2535896A1 N-substituted benzimidazolyl c-kit inhibitors
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005CA2533175A1 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
03/09/2005EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators
03/09/2005EP1511734A2 Compounds, compositions, and methods
03/09/2005EP1511727A2 Aromatic sulfones and their medical use
03/09/2005EP1511491A1 Derivatives of azepine and thiazepan as interleukin converting enzyme inhibitors
03/09/2005EP0869792B1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
03/09/2005CN1592746A LFA-1 antagonist compounds
03/09/2005CN1592745A Therapeutic chromone compounds
03/09/2005CN1592744A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
03/09/2005CN1592743A Inhibitors of glycogen synthase kinase 3
03/09/2005CN1592739A Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
03/09/2005CN1590386A Sidechain-bearing taxanes and method for the preparation thereof
03/09/2005CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof
03/09/2005CN1590375A TNF-alpha prodn. inhibitors
03/09/2005CN1590374A TNF-alpha prodn. inhibitors
03/09/2005CN1192031C Epothilones derivatives, their synthesis and uses
03/09/2005CN1192021C 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864273 Dyspepsia; gastrointestinal disorders; irritable bowel disorders
03/08/2005US6864270 Iron binding agents
03/08/2005US6864265 Chemokine receptor binding heterocyclic compounds
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/08/2005US6864255 Substituted triazinyl amide derivatives and methods of use
03/08/2005US6864250 N-acylated lipophilic amino acid derivatives
03/08/2005US6864249 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants.
03/08/2005US6863647 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
03/03/2005WO2005019216A1 Aminobenzimidazole derivatives
03/03/2005WO2005019213A1 N-aryl-2-cyanooxazolidinones and their derivatives
03/03/2005WO2005019211A2 Biaryl heterocyclic compounds and methods of making and using the same
03/03/2005WO2005019206A1 Mitotic kinesin inhibitors
03/03/2005WO2005019205A1 Mitotic kinesin inhibitors
03/03/2005WO2005019200A2 Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof
03/03/2005WO2005019190A2 (4 -amino -1,2, 5-oxadiazol-4-yl) -hetξroaromatic compounds useful as protein kinase inhibitors
03/03/2005WO2005019177A1 Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof
03/03/2005WO2005018557A2 Substituted pyridinones
03/03/2005WO2005018531A2 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
03/03/2005WO2005000309A3 Chemical compounds
03/03/2005WO2005000298A3 5-membered heterocycle-based p-38 inhibitors
03/03/2005WO2004110350A3 Compouds and uses thereof in modulating amyloid beta
03/03/2005WO2004101553B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
03/03/2005WO2004083235A3 Tie-2 modulators and methods of use
03/03/2005WO2003089418A8 Indane acetic acid derivatives and their use as pharmaceutical agents
03/03/2005US20050049290 Benzimidazole derivatives and their use as gnrh antagonists
03/03/2005US20050049274 Selective, potent small molecule protein tyrosine kinase inhibitors; such as 6-chloro-3-(3-methyl-isoxazol-5-yl)-4-(pyridin-4-yl)-1H-quinolin-2-one
03/03/2005US20050049269 For therapy of metabolic and eating disorders
03/03/2005US20050049264 Suppressing growth of abnormal cells; gastric, brain, colon, pancreatic, lung, renal, ovarian and prostatic cancer
03/03/2005US20050049258 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease
03/03/2005US20050049254 Substituted heterocyclic compounds
03/03/2005US20050049244 osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis
03/03/2005US20050049237 Pyrazole-amides and -sulfonamides
03/03/2005US20050048315 Such as 4-(dicyanomethylene)-2-{p-(dialkylamino)styryl}-6-{p-(diarylamino)styryl}-4H-pyran; improved carrier transportation and exhibits long wavelength light
03/03/2005DE10334309A1 Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung Substituted thiazol-Benzoisothiazoldioxidderivate, processes for their preparation and their use
03/03/2005CA2536313A1 Fused pyrimidine derivative and use thereof
03/03/2005CA2536253A1 Aminofurazan compounds useful as protein kinase inhibitors
03/03/2005CA2536173A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/03/2005CA2536095A1 Aminobenzimidazole derivatives
03/03/2005CA2535796A1 N-aryl-2-cyanooxazolidinones and their derivatives
03/03/2005CA2528089A1 Biaryl heterocyclic compounds and methods of making and using the same
03/02/2005EP1510515A1 Phenylglycine derivatives as serine protease inhibitors
03/02/2005EP1509532A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
03/02/2005EP1509516A1 Inhibitors of the gpib -vwf interaction, their preparation and use
03/02/2005EP1509509A1 Glucagon antagonists/inverse agonists
03/02/2005EP1509507A2 Mitotic kinesin inhibitors
03/02/2005EP1509499A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases
03/02/2005EP1509249A2 Inclusion complexes of rosiglitazone
03/02/2005EP1509224A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
03/02/2005EP1509216A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
03/02/2005EP1509213A2 Acetamides and benzamides that are useful in treating sexual dysfunction
03/02/2005EP1278741B1 Muscarinic agonists
03/02/2005EP1129084B1 Thiazole derivatives as ppar gamma ligands
03/02/2005CN1589270A Indole-2-formamide compounds as factor Xa inhibitors
03/02/2005CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
03/02/2005CN1589260A Heterocyclic compounds and methods of use thereof
03/02/2005CN1589146A Benzothiazole derivatives as adenosine receptor ligands
03/02/2005CN1191252C 3-position substituted quinolone derivativers and its use in pharmacy
03/02/2005CN1191247C Substituted guanidine derivatives
03/02/2005CN1191233C N-substituted nitrogen heterocyclic compound
03/01/2005US6861530 Piperidine derivatives
03/01/2005US6861522 Process for the manufacture of thiazole derivatives with pesticidal activity
03/01/2005US6861440 Antidiabetic agents
03/01/2005US6861432 Piperazine derivatives that destabilize androgen receptors
1 ... 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 ... 628